Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Review ArticleClinical Review

Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma

Role of primary care physicians

Joel B. Epstein, Meir Gorsky, Robert J. Cabay, Terry Day and Wanda Gonsalves
Canadian Family Physician June 2008, 54 (6) 870-875;
Joel B. Epstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jepstein@uic.edu
Meir Gorsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J. Cabay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terry Day
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanda Gonsalves
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

ABSTRACT

OBJECTIVE To describe the role that primary care physicians can play in early recognition of oral and oropharyngeal squamous cell carcinomas (OOSCCs) and to review the risk factors for OOSCCs, the nature of oral premalignant lesions, and the technique and aids for clinical examination.

QUALITY OF EVIDENCE MEDLINE and CANCERLIT literature searches were conducted using the following terms: oral cancer and risk factors, pre-malignant oral lesions, clinical evaluation of abnormal oral lesions, and cancer screening. Additional articles were identified from key references within articles. The articles contained level I, II, and III evidence and included controlled trials and systematic reviews.

MAIN MESSAGE Most OOSCCs are in advanced stages at diagnosis, and treatment does not improve survival rates. Early recognition and diagnosis of OOSCCs might improve patient survival and reduce treatment-related morbidity. Comprehensive head and neck examinations should be part of all medical and dental examinations. The head and neck should be inspected and palpated to evaluate for OOSCCs, particularly in high-risk patients and when symptoms are identified. A neck mass or mouth lesion combined with regional pain might suggest a malignant or premalignant process.

CONCLUSION Primary care physicians are well suited to providing head and neck examinations, and to screening for the presence of suspicious oral lesions. Referral for biopsy might be indicated, depending on the experience of examining physicians.

Oral cancer most often refers to squamous cell carcinoma of the oral cavity (the anatomic region that extends from the lip to the junction of the hard and soft palate superiorly and the vallate papillae of the tongue inferiorly). Oropharyngeal cancers include cancers of the base of the tongue, tonsil, soft palate, and posterior pharyngeal wall. Many oropharyngeal cancers are difficult to see, even when using a tongue blade and light source.

Approximately three-quarters of oral and oropharyngeal squamous cell carcinomas (OOSCCs) occur among those living in developing countries. In Southeast Asia, OOSCCs account for 40% of all cancers compared with approximately 4% in developed countries.1–3 The American Cancer Society estimates that approximately 30 000 new cases of OOSCCs are diagnosed and more than 8000 people die of these cancers in the United States each year.4 In England, the incidence of OOSCCs is 4/100 000 per year across all age groups, but more than 30 cases per 100 000 are diagnosed among those older than 65 years of age.5 More than 90% of OOSCCs occur among patients older than 40 years of age.6

Eighty-one percent of patients with OOSCCs will survive for at least 1 year following diagnosis, while the 5-year relative survival rate for all stages of OOSCCs is approximately 50%.4 Unfortunately, the 5-year survival rate has not changed substantially in the past few decades, despite advances in surgery, radiation therapy, and chemotherapy.7,8 For early stage OOSCCs (stage I and II), the 5-year relative survival rate is approximately 80%; whereas for advanced disease (stage III and IV), the 5-year survival rate is less than 25%.4–7 In addition, advanced disease requires more aggressive therapy, employing combined treatments that might result in increased morbidity and cost of care and reduced quality of life. The most logical approach to decreasing morbidity and mortality associated with OOSCCs is to increase detection of suspicious oral premalignant lesions (OPLs) and early detection of OOSCCs. Educating medical and dental professionals and the public about the benefits of preventive screening might help achieve this goal.

The purpose of this article is to review and update the risk factors for OOSCCs, the nature of OPLs, and the technique and aids for clinical examination for reliable clinical screening, and to describe the role that primary care physicians can play in early recognition of OOSCCs.

Quality of evidence

MEDLINE and CANCERLIT literature searches were conducted using the following terms: oral cancer and risk factors, pre-malignant oral lesions, clinical evaluation of abnormal oral lesions, and cancer screening. Additional articles were identified from key references within articles. The articles contained level I, II, and III evidence and included controlled trials and systematic reviews.

Risk factors

Oral and oropharyngeal squamous cell carcinomas are associated with several well-recognized etiologic risk factors (Table 1). Patients with higher relative risks of developing OOSCCs include those with history of tobacco and alcohol use. More than 70% of patients with OOSCCs report history of tobacco use,9 and about 80% of cases are associated with alcohol or tobacco abuse.10 The risk of OOSCCs increases approximately ninefold among those individuals who have had prior upper aerodigestive tract cancer, compared with the general population.11 Similarly, 20% to 30% of patients with prior history of upper aerodigestive tract cancer develop recurrent disease or second primary cancers.12 The risk of second primary cancers is greater than that attributable to continued tobacco or alcohol use, suggesting that host risk factors further increase the risk of OOSCCs.13

View this table:
  • View inline
  • View popup
Table 1

Risk factors for oral premalignant lesions and oropharyngeal squamous cell carcinoma

Other reported risk factors for OOSCCs include the following: betel nut chewing; oral human papillomavirus (HPV) infection; and chronic immunosuppression following solid organ transplant, hematopoietic cell transplant, and, possibly, HIV infection and AIDS. For example, squamous cell carcinoma of the tonsil has the highest prevalence of HPV-16 DNA among the OOSCCs, suggesting increased risk associated with HPV in this location.14 In addition to tobacco and alcohol use, HPV infection, immunodeficiency, and, possibly, genetic changes represent risk factors for OOSCCs among patients with HIV infection.14–18 Individuals older than 45 years of age and African Americans also have higher risks of OOSCCs.3,19

Oral premalignant lesions

Oral premalignant lesions include leukoplakia, erythroplakia, dysplastic leukoplakia, dysplastic lichenoid lesion, oral submucous fibrosis, and lichen planus (Figures 1–3). The clinical presentations of oral mucosal lesions are presented in Table 2. Oral premalignant lesions have shown a rate of progression of up to 17% within a mean period of 7 years after diagnosis. The highest transformation rate is seen in those lesions with clinically irregular or heterogeneous erythroplakia and dysplastic changes.20,21 Features of OPLs associated with risk of progression to cancer include colour (red, red-white), irregularity (lack of homogeneity), surface texture (granular, verrucous), and location (floor of mouth, ventral or posterolateral border of the tongue).6,22 Ultrastructural changes, including phenotypic change (the presence and severity of dysplasia), DNA instability, and allelic loss (particularly involving chromosome arms 3p, 9p, and 17p, and other molecular markers), affect the risk of developing OOSCCs.22,23

Figure 1
  • Download figure
  • Open in new tab
Figure 1

Irregular leukoplakia (verrucous leukoplakia) with squamous cell carcinoma in the upper right vestibule where a mass can be seen, and dysplasia in the remaining leukoplakia

Figure 2
  • Download figure
  • Open in new tab
Figure 2

Asymptomatic red (erythroplakic) lesion involving the soft palate and tonsillar fossa, diagnosed as squamous cell carcinoma

Figure 3
  • Download figure
  • Open in new tab
Figure 3

Mixed red and white lesion on the floor of the mouth, a high-risk site for cancer

View this table:
  • View inline
  • View popup
Table 2 Clinical presentations of oral mucosal lesions

Risk sites include the posterolateral border of the tongue, the floor of the mouth, and the oropharynx (tonsil, base of tongue).

Screening

Population-based screening programs for OPLs and OOSCCs are costly given the low number of lesions in the general population in developed countries. Screening performed by professionals, although more accurate, is more expensive than screening performed by health care auxiliaries.24 Patient participation and settings vary, and economic constraints make it necessary to direct screening efforts toward high-risk individuals.25–29 A simulation model of population screening for OPLs and OOSCCs indicated that approximately 18 000 patients would need to be screened in order to save 1 life.30 This rate is comparable to that for cervical cancer. Therefore, incidental screening has been suggested when patients are seen for other examinations by health care providers. Primary care physicians can provide this type of screening for OPLs and OOSCCs in target individuals.

Definitive guidelines for screening of oral cancer are not well established. The most recent US Preventive Services Task Force report (2004) found insufficient evidence to recommend for or against screening for oral cancer among smokers older than 50 and those at low risk.31 The task force found little data on sensitivity and specificity of oral examination for cancer (level II and III evidence). Opportunistic oral cancer screening is recommended by the Canadian Dental Association and the American Dental Association; these organizations emphasize that early detection allows treatment at earlier stages of disease (level III evidence).32,33 The Canadian Task Force on Preventive Health Care reported that there was insufficient evidence to recommend for or against opportunistic screening and fair evidence to exclude population screening for oral cancer; they did, however, recommend annual examinations for high risk patients (level II evidence).34 Other authors have argued that targeted clinical examination of high-risk individuals might be more effective than mass screening in facilitating early detection of oral cancers.35 Clinical examination appears to provide valid screening, especially when performed by highly trained health care personnel. A recent study in India enrolled nearly 100 000 patients who received oral examinations and compared their outcomes with those of a similarly sized control group not given oral screening examinations (level evidence).36 Among those screened, 205 oral cancers were diagnosed and 77 patients died of oral cancer; in the control population, 158 oral cancers were diagnosed and 87 patients died of oral cancer. Screening examinations were, therefore, associated with reduced mortality among high-risk patients.

Self-examination might be a cost-effective option for OPL and OOSCC screening. A study that examined the feasibility of self-examination of the oral cavity37 reported that of 247 subjects presenting to the participating clinics, 6 (2.4%) had stage I OOSCCs, and only 1 individual was diagnosed with an advanced stage of disease. The detection rate of oral cancer following self-examination compared favourably with examination by trained health care workers.37

Examination

The examination (Figure 4) must include a comprehensive inspection of the head and neck, with assessment of cervical lymph nodes and cranial nerve function. A neck mass or mouth lesion combined with regional pain might suggest a malignant or premalignant process. A gloved hand and tongue blade or dental mirror can be used to retract the lips and extend the cheeks for visual examination and palpation. Use gauze wrapped around the tongue to assist with retraction and examination of the lateral borders of the tongue. A white light source (halogen) provides the best illumination with colour balance. The highest risk oral sites, including the lateral borders of the tongue, the floor of the mouth, the posterior aspect of the cheek, and the oropharynx, must be evaluated. The first site of spread of OOSCCs beyond the aerodigestive tract is usually to the cervical lymph nodes. Palpation of these nodes must be included as part of every comprehensive head and neck examination. Any lymph node larger than 1 cm should be noted, and the patient should be referred for further evaluation and diagnosis. Some patients with OOSCCs initially present with enlarged lymph nodes without any other signs or symptoms.

Figure 4
  • Download figure
  • Open in new tab
Figure 4

Oral, head, and neck examination

The head and neck examination should include inspection and palpation of the cheeks, parotid glands, and submandibular glands. Asymmetry should be noted and any cutaneous lesions assessed. Intraoral examination is best accomplished with an external light source that enables both hands to be free to retract the cheeks, buccal mucosa, tongue, and lips, allowing full view of all mucosal surfaces. Most hospital rooms do not have appropriate external light sources and require physicians to hold light sources, such as penlights, otoscopes, or ophthalmoscopes, to illuminate the oral cavity. Unfortunately, this prevents a bimanual examination. Examination of the oropharynx, nasopharynx, and larynx is important in any patient with OOSCCs in order to search for second primary tumours and for risk factors and symptoms, including odynophagia, dysphagia, sore throat, or dysphonia. This type of examination requires a mirror and a fiberoptic nasopharyngoscope or laryngoscope. If these are not available, referral to an otolaryngologist might be indicated.

Various aids have been advocated to assist in early detection of OPLs and OOSCCs, but these have not yet been incorporated into guidelines.38 Examination adjuncts have been compared with standard examinations among high-risk or referred populations in several trials providing level II evidence. One randomized controlled trial of toluidine blue provided level I evidence.39 Use of toluidine blue, as a mouth rinse or applied with cotton-tipped applicators to sites of tissue change, has been advocated for identifying lesions, accelerating decision to biopsy, and guiding biopsy site selection.39 Chemiluminescence might make OPLs easier to see; it is used as an adjunct to the Papanicolaou smear to increase detection of dysplastic and neoplastic changes in the cervix.40,41 One study of chemiluminescence for detection of oral lesions found that although white lesions and lesions that were both red and white showed enhanced brightness and sharpness, chemiluminescence did not make red lesions more visible.42 A recent multicentre trial that assessed patients following visual examination with chemiluminescence and toluidine blue applied with swabs found that stain retention reduced the false-positive rate by 55% while maintaining a 100% negative predictive value (level I evidence).43 Additional trials (level II evidence) have assessed tissue autofluorescence in patients known to have cancer and found it to have high sensitivity and specificity,44,45 although this technology has not been applied in noncancer patient evaluations and the role in screening is unknown. Additionally, an exfoliative cytology (brush-type “biopsy”) technique has been developed for accumulating cellular samples of deeper epithelial layers for computerized morphologic and cytologic examination followed by pathologist review.46 Definitive diagnosis, however, requires an open biopsy.

Conclusion

The oral cavity and oropharynx are important areas that should be carefully inspected and palpated, particularly in tobacco and alcohol users, to evaluate for oral and oropharyngeal cancer. A red or white patch or a change in colour, texture, size, contour, mobility, or function of intraoral, perioral, or extraoral tissue should arouse suspicion of the presence of malignant or premalignant lesions in these regions. Comprehensive head and neck examinations should be part of all medical and dental examinations. Primary care physicians are well suited to providing head and neck examinations and to screening for the presence of suspicious lesions. Referral for biopsy and further diagnosis might be indicated, depending on the experience of examining physicians. In the future, examination and screening for oral and oropharyngeal cancers will likely include novel technologies aimed at detecting molecular markers of premalignant and malignant changes.

Levels of evidence

Level I: At least one properly conducted randomized controlled trial, systematic review, or meta-analysis

Level II: Other comparison trials, non-randomized, cohort, case-control, or epidemiologic studies, and preferably more than one study

Level III: Expert opinion or consensus statements

Notes

EDITOR’S KEY POINTS

  • Oral and oropharyngeal cancers account for 4% of cancers in developed countries and up to 40% in developing countries. Risk factors include tobacco and alcohol use.

  • The Canadian Task Force on Preventive Health Care does not recommend population screening but suggests annual examinations for those at high risk.

  • Careful clinical examination is essential for the early detection of oral and oropharyngeal cancers. Examination adjuncts, such as toluidine blue, can be helpful in identifying suspicious lesions.

  • Definitive diagnosis requires a biopsy.

POINTS DE REPÈRE DU RÉDACTEUR

  • Les cancers oraux et oro-pharyngés représentent 4% des cancers dans les pays développés et jusqu’à 40% dans les pays en voie de développement. Les facteurs de risque incluent le tabagisme et la consommation d’alcool.

  • Le Groupe d’Étude Canadien sur les Soins de Santé Préventifs ne préconise pas de dépistage universel mais suggère plutôt des examens annuels pour les sujets à risque élevé.

  • La détection précoce des cancers oraux et oro-pharyngés exige un examen clinique minutieux. Des examens accessoires comme le bleu de toluidine peuvent être utiles pour identifier les lésions.

  • Le diagnostic définitif requiert une biopsie.

Footnotes

  • Competing interests

    Dr Epstein is a member of the advisory board for and has received research funding from Zila Pharmaceuticals Inc.

  • Cet article a fait l’objet d’une révision par des pairs.

  • This article has been peer reviewed.

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    American Cancer SocietyWhat are the key statistics about oral cavity and oro-pharyngeal cancer?Tucson, AZAmerican Cancer Society2006Available from: www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_oral_cavity_and_oropharyngeal_cancer_60.asp?sitearea=Accessed 2007 Jan 18
  2. MacfarlaneGJBoylePEvstifeevaTVRobertsonCScullyCRising trends of oral cancer mortality among males worldwide: the return of an old public health problemCancer Causes Control19945325965
    OpenUrlCrossRefPubMed
  3. ↵
    RiesLAGKosaryCLHankeyBFMillerBACleggLEdwardsBKSEER cancer statistics review, 1973–1996.Bethesda, MDNational Cancer Institute1999
  4. ↵
    American Cancer SocietyCancer facts & figures 2004Atlanta, GAAmerican Cancer Society2004Available from: www.cancer.org/docroot/STT/content/STT_1x_Cancer_Facts__Figures_2004.aspAccessed 2007 Jan 18
  5. ↵
    DownerMCPatterns of disease and treatment and their implications for dental health services researchCommunity Dent Health199310Suppl 23946
    OpenUrlPubMed
  6. ↵
    ShiboskiCHShiboskiSCSilvermanSJrTrends in oral cancer rates in the United States, 1973–1996Community Dent Oral Epidemiol200028424956
    OpenUrlCrossRefPubMed
  7. ↵
    SilvermanSJrDemographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challengeJ Am Dent Assoc2001132Suppl 17S11S
    OpenUrlAbstract/FREE Full Text
  8. ↵
    National Cancer InstituteSurveillance, Epidemiology, and End Results program public-use data, 1973–1998Rockville, MDNational Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch2001
  9. ↵
    SilvermanSJrGorskyMGreenspanDTobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancersJ Am Dent Assoc19831061335
    OpenUrlAbstract
  10. ↵
    CastellsagueXQuintanaMJMartinezMCNietoASánchezMJJuanAThe role of type of tobacco and type of alcoholic beverage in oral carcinogenesisInt J Cancer200410857419
    OpenUrlCrossRefPubMed
  11. ↵
    JovanovicAvan der TolIGSchultenEAKostensePJde VriesNSnowGBRisk of multiple primary tumors following oral squamous-cell carcinomaInt J Cancer19945633203
    OpenUrlPubMed
  12. ↵
    WarnakulasuriyaKARobinsonDEvansHMultiple primary tumours following head and neck cancer in southern England during 1961–98J Oral Pathol Med20033284439
    OpenUrlCrossRefPubMed
  13. ↵
    SchantzSPSpitzMRHsuTCMutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignanciesJ Natl Cancer Inst1990822217735
    OpenUrlFREE Full Text
  14. ↵
    GrossGGundlachKReichartPAVirus infections and tumors of the oral mucosae. Symposium of the “Arbeitskreis Oralpathologie und Oralmedizin” and the “Arbeitsgemeinschaft Dermatologische Infektiologie der Deutschen Dermatologischen Gesellschaft,” Rostock, July 6–7, 2001Eur J Med Res200161044058
    OpenUrlPubMed
  15. RegeziJADekkerNPRamosDMLiXMacabeo-OngMJordanRCProliferation and invasion factors in HIV-associated dysplastic and nondysplastic oral warts and in oral squamous cell carcinoma: an immunohistochemical and RT-PCR evaluationOral Surg Oral Med Oral Pathol Oral Radiol Endod200294672431
    OpenUrlPubMed
  16. PiattelliARubiniCFioroniMIezziTWarty carcinoma of the oral mucosa in an HIV+ patientOral Oncol20013786657
    OpenUrlPubMed
  17. AnilSBeenaVTNairRGSquamous cell carcinoma of the gingiva in an HIV-positive patient: a case reportDent Update199623104245
    OpenUrlPubMed
  18. ↵
    FlaitzCMHicksMJMolecular piracy: the viral link to carcinogenesisOral Oncol199834644853
    OpenUrlCrossRefPubMed
  19. ↵
    HayJLOstroffJSCruzGDLeGerosRZKenigsbergHFranklinDMOral cancer risk perception among participants in an oral cancer screening programCancer Epidemiol Biomarkers Prev20021121558
    OpenUrlAbstract/FREE Full Text
  20. ↵
    SilvermanSJrGorskyMLozadaFOral leukoplakia and malignant transformation. A follow-up study of 257 patientsCancer19845335638
    OpenUrlCrossRefPubMed
  21. ↵
    SchepmanKPvan der MeijEHSmeeleLEvan der WaalIMalignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The NetherlandsOral Oncol19983442705
    OpenUrlCrossRefPubMed
  22. ↵
    ZhangLCheungKJJrLamWLChengXPohCPriddyRIncreased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical managementCancer20019111214855
    OpenUrlCrossRefPubMed
  23. ↵
    RosinMPChengXPohCLamWLHuangYLovasJUse of allelic loss to predict malignant risk for low-grade oral epithelial dysplasiaClin Cancer Res20006235762
    OpenUrlAbstract/FREE Full Text
  24. ↵
    JullienJADownerMCSpeightPMZakrzewskaJMEvaluation of health care workers’ accuracy in recognizing oral cancer and pre-cancerInt Dent J19964643349
    OpenUrlPubMed
  25. ↵
    ZakrzewskaJMMartinICOral cancer screeningBr Dent J200018931245
    OpenUrlPubMed
  26. NagaoTWarnakulasuriyaSIkedaNFukanoHFujiwaraKMiyazakiHOral cancer screening as an integral part of general health screening in Tokoname City, JapanJ Med Screen2000742038
    OpenUrlAbstract/FREE Full Text
  27. WarnakulasuriyaSPindborgJJReliability of oral precancer screening by primary health care workers in Sri LankaCommunity Dent Health199071739
    OpenUrlPubMed
  28. JullienJAZakrzewskaJMDownerMCSpeightPMAttendance and compliance at an oral cancer screening programme in general medical practiceEur J Cancer B Oral Oncol199531B32026
    OpenUrl
  29. ↵
    NagaoTIkedaNFukanoHMiyazakiHYanoMWarnakulasuriyaSOutcome following a population screening programme for oral cancer and precancer in JapanOral Oncol20003643406
    OpenUrlCrossRefPubMed
  30. ↵
    DownerMCMolesDRPalmerSSpeightPMA systematic review of test performance in screening for oral cancer and precancerOral Oncol200440326473
    OpenUrlCrossRefPubMed
  31. ↵
    US Preventive Services Task ForceScreening for oral cancerRockville, MDAgency for Healthcare Research and Quality2004Available from: www.ahrq.gov/clinic/uspstf/uspsoral.htmAccessed 2008 Apr 18
  32. ↵
    Canadian Dental AssociationOral cancerOttawa, ONCanadian Dental Association2005Available from: www.cda-adc.ca/en/oral_health/complications/diseases/oral_cancer.aspAccessed 2008 May 6
  33. ↵
    American Dental AssociationOral cancerChicago, ILAmerican Dental Association2007Available from: www.ada.org/public/topics/cancer_oral.aspAccessed 2008 May 6
  34. ↵
    HawkinsRJWangEELeakeJLPreventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health CareJ Can Dent Assoc19996511617
    OpenUrlPubMed
  35. ↵
    PattonLLThe effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancerOral Oncol200339770823
    OpenUrlCrossRefPubMed
  36. ↵
    SankaranarayananRRamadasKThomasGMuwongeRTharaSMathewBEffect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trialLancet20053659475192733
    OpenUrlCrossRefPubMed
  37. ↵
    MathewBSankaranarayananRWesleyRNairMKEvaluation of mouth self-examination in the control of oral cancerBr J Cancer19957123979
    OpenUrlPubMed
  38. ↵
    MashbergABarsaPScreening for oral and oropharyngeal squamous carcinomasCA Cancer J Clin19843452628
    OpenUrlCrossRefPubMed
  39. ↵
    EpsteinJBFeldmanRDolorRJPorterSRThe utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancerHead Neck2003251191121
    OpenUrlCrossRefPubMed
  40. ↵
    YuBKKuoBIYenMSTwuNFLaiCRChenPJImproved early detection of cervical intraepithelial lesions by combination of conventional Pap smear and speculoscopyEur J Gynaecol Oncol20032464959
    OpenUrlPubMed
  41. ↵
    LonkyNMMannWJMassadLSMutchDGBlancoJSVasilevSAAbility of visual tests to predict underlying cervical neoplasia. Colposcopy and speculoscopyJ Reproduct Med19954075306
    OpenUrl
  42. ↵
    EpsteinJBGorskyMLonkySSilvermanSJrEpsteinJDBrideMThe efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesionsSpec Care Dentist20062641714
    OpenUrlPubMed
  43. ↵
    EpsteinJBSilvermanSJrEpsteinJDLonkySABrideMAAnalysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blueOral Oncol2007Nov 8Epub ahead of print
  44. ↵
    PohCFZhangLAndersonDWDurhamJSWilliamsPMPriddyRWFluorescence visualization detection of field alterations in tumor margins of oral cancer patientsClin Cancer Res20061222671622
    OpenUrlAbstract/FREE Full Text
  45. ↵
    LanePMGilhulyTWhiteheadPZengHPohCFNgSSimple device for the direct visualization of oral-cavity tissue fluorescenceJ Biomed Opt2006112024006
    OpenUrlCrossRefPubMed
  46. ↵
    SciubbaJJImproving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. US Collaborative OralCDx Study GroupJ Am Dent Assoc199913010144557
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

Canadian Family Physician: 54 (6)
Canadian Family Physician
Vol. 54, Issue 6
1 Jun 2008
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma
Joel B. Epstein, Meir Gorsky, Robert J. Cabay, Terry Day, Wanda Gonsalves
Canadian Family Physician Jun 2008, 54 (6) 870-875;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma
Joel B. Epstein, Meir Gorsky, Robert J. Cabay, Terry Day, Wanda Gonsalves
Canadian Family Physician Jun 2008, 54 (6) 870-875;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Quality of evidence
    • Risk factors
    • Oral premalignant lesions
    • Screening
    • Examination
    • Conclusion
    • Levels of evidence
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The limitations of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma
  • A Case Study Associated with Oropharyngeal Cancer
  • Google Scholar

More in this TOC Section

  • Buprenorphine-naloxone microdosing
  • Approach to hearing loss
  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
Show more Clinical Review

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2021 by The College of Family Physicians of Canada

Powered by HighWire